At VentiraDx, we believe innovation should do more than improve signal detection. It should also expand research utility, simplify laboratory operations, and enable more powerful molecular insight.
Our portfolio spans oncology research, infectious disease research, digital PCR, advanced FISH technologies, and ultra-sensitive protein analysis. By combining novel assay design, robust signal performance, and automation-ready workflows, we aim to help laboratories generate more precise, reproducible, and actionable research results.


